VRCA
Verrica Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.44
−4.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 13.72x
- Price / sales
- 1.95x
- Price / cash flow
- -4.43x
Enterprise value
- Enterprise value
- $49.7M
- EV / sales
- 1.64x
- EV / EBITDA
- -1.86x
- EV / EBIT
- -1.77x
- Market cap
- $59.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026